American Academy of Child and Adolescent Psychiatry 57th Annual Meeting (October 26-31, 2010) Program Schedule
Please note that this schedule is subject to change.

New Research Poster Presentation 3.58
Improvement in Social Withdrawal and Global Measures of Behavior in Fragile X Syndrome: Results of a Randomized, Controlled, Phase 2 Trial of Arbaclofen
Thursday, October 28, 2010
Jeremy Veenstra-VanderWeele, M.D., Kennedy Center for Research on Human Development, Nashville, TN
Elizabeth Berry-Kravis, M.D., Ph.D., Pediatrics, Neurology, Biochemistry, Rush University, Chicago, IL
Barbara Rathmell, M.D., Seaside Therapeutics, Inc., Cambridge, MA
Maryann Cherubini, B.S., Seaside Therapeutics, Inc., Cambridge, MA
Peter Zarevics, B.S., Seaside Therapeutics, Inc., Cambridge, MA
Paul Wang, M.D., Seaside Therapeutics, Inc., Cambridge, MA
Randall L. Carpenter, M.D., Seaside Therapeutics, Inc., Cambridge, MA
Mark Bear, Ph.D., Picower Institute of Learning and Memory, Howard Hughes Medical Institute and Massachusetts Institute of Technology, Cambridge, MA
Randi Hagerman, M.D., MIND Institute & Department of Pediatrics, University of California, Davis Medical Center, Sacramento, CA
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.